Efficacy of empagliflozin to type 2 diabetic patients with ICD
Phase 4
- Conditions
- Type2 Diabetes
- Registration Number
- JPRN-jRCTs031180120
- Lead Sponsor
- Minamino Tohru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Over 20 years
Patients with ICD
Type2 Diabetes
Exclusion Criteria
Liver disease with ALT, AST or ALP x3 ULN
Planned CV surgery, angioplasty, stroke and heart failure hospitalization in 6 month
eGFR <30 mL/min/1.73 m2 by MDRD equation
Nutritional disorders
Cancer
Nursing, pregnant, or child-bearing age women not using acceptable method of birth control or refusing pregnancy testing
Alcohol abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method